Related Experiment Video
Updated: Apr 10, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
Published on: July 7, 2014
New Insights for Oxidative Stress and Diabetes Mellitus
1Laboratory of Cellular and Molecular Signaling, Newark, NJ 07101, USA.
Abstract:
The release of reactive oxygen species (ROS) and the generation of oxidative stress are considered critical factors for the pathogenesis of diabetes mellitus (DM), a disorder that is growing in prevalence and results in significant economic loss. New therapeutic directions that address the detrimental effects of oxidative stress may be especially warranted to develop effective care for the millions of individuals that currently suffer from DM. The mechanistic target of rapamycin (mTOR), silent mating type information regulation 2 homolog 1 (S. cerevisiae) (SIRT1), and Wnt1 inducible signaling pathway protein 1 (WISP1) are especially justified to be considered treatment targets for DM since these pathways can address the complex relationship between stem cells, trophic factors, impaired glucose tolerance, programmed cell death pathways of apoptosis and autophagy, tissue remodeling, cellular energy homeostasis, and vascular biology that greatly impact the biology and disease progression of DM. The translation and development of these pathways into viable therapies will require detailed understanding of their proliferative nature to maximize clinical efficacy and limit adverse effects that have the potential to lead to unintended consequences.
Insights
Oxidative stress contributes to diabetes mellitus (DM). Targeting pathways like mTOR, SIRT1, and WISP1 may offer new therapies for DM by addressing stem cells, energy, and vascular issues.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Oxidative stress and reactive oxygen species (ROS) play a critical role in the pathogenesis of diabetes mellitus (DM).
- The increasing prevalence of DM necessitates novel therapeutic strategies to mitigate the harmful effects of oxidative stress.
- Understanding the intricate molecular pathways involved in DM is crucial for developing effective treatments.
Purpose of the Study:
- To identify and evaluate key molecular targets for novel diabetes mellitus (DM) therapies.
- To explore the potential of mechanistic target of rapamycin (mTOR), silent mating type information regulation 2 homolog 1 (SIRT1), and Wnt1 inducible signaling pathway protein 1 (WISP1) as therapeutic targets for DM.
- To investigate the complex interplay between cellular pathways and DM progression.
Main Methods:
- Literature review and pathway analysis focusing on mTOR, SIRT1, and WISP1 in the context of DM.
- Examination of the relationship between these pathways and stem cell function, glucose tolerance, apoptosis, autophagy, tissue remodeling, energy homeostasis, and vascular biology.
- Assessment of the proliferative nature of identified pathways for therapeutic development.
Main Results:
- The mechanistic target of rapamycin (mTOR), silent mating type information regulation 2 homolog 1 (SIRT1), and Wnt1 inducible signaling pathway protein 1 (WISP1) pathways are implicated in critical aspects of DM.
- These pathways influence stem cell behavior, glucose metabolism, programmed cell death (apoptosis and autophagy), tissue repair, energy balance, and vascular health in DM.
- Understanding the proliferative characteristics of these pathways is key to their therapeutic application.
Conclusions:
- Targeting mTOR, SIRT1, and WISP1 pathways presents a promising therapeutic avenue for managing diabetes mellitus (DM).
- Further research into these pathways can lead to the development of effective treatments that address the multifaceted nature of DM.
- Translating this knowledge into clinical practice requires a thorough understanding of pathway dynamics to optimize efficacy and minimize side effects.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

